I guess completely ignoring ERHCs problems and sticking our heads in the sand are the only things that are acceptable topics of discussion. Telling the complete truth and openly discussing ERHCs problems, screw-ups and shortcomings is deemed way too negative to even discuss.
When you have 2 billion shares of dilution, a 100:1 reverse split, a .0011 share price and a non-communicating, uninspiring management it's a stretch to say we shouldn't be so negative. If ERHC had more positives we would be talking about those instead. Unfortunately it is difficult to find anything positive, but I'll keep looking.
Market Data 
Markets 
AI
